Stay updated on Magrolimab vs. Venetoclax in TP53 AML Clinical Trial
Sign up to get notified when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.

Latest updates to the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.6.1, replacing Revision: v3.6.0. This reflects a release update to the page's version metadata and does not indicate changes to the study details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now includes new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and displays the recruitment update 'No longer looking for participants', while the 'Intervention / Treatment' label has been updated to 'Intervention/Treatment' and the revision version updated to v3.6.0, reflecting a mix of usability improvements and formatting/documentation updates.SummaryDifference0.2%

- Check27 days agoChange DetectedAdded the revision tag 'Revision: v3.5.5' and removed 'Revision: v3.5.4', signaling a minor update to the page's revision metadata.SummaryDifference0.0%

- Check42 days agoChange DetectedA new document revision, Revision: v3.5.4, was added to the study record, replacing Revision: v3.5.3. This update indicates an updated version of the study protocol and related documentation.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.5.3 was added and Revision: v3.5.2 was removed. This indicates a minor version update to the page rather than a change to the study details.SummaryDifference0.0%

- Check70 days agoChange DetectedVersion bumped from 3.5.0 to 3.5.2.SummaryDifference0.0%

Stay in the know with updates to Magrolimab vs. Venetoclax in TP53 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.